KKR’s Gamma Biosciences makes Astrea deal with Biotage; Inflexion to take dss stake from Gyrus

Inflexion has agreed to buy a majority stake in Swiss operations management consulting firm dss from Gyrus Capital.

EuropeUKWestern EuropeCommentaryPE Hub Wire